NEW YORK (Reuters Health) – Left atrial volume rather than diameter is more strongly associated with thromboembolic risk markers in patients with mitral stenosis, and should be used…
NEW YORK (Reuters Health) – The antiplatelet effect of clopidogrel is much reduced in patients undergoing therapeutic hypothermia after cardiac arrest, according to a Norwegian study published online…
NEW YORK (Reuters Health) – The risk of developing post-pericardiotomy syndrome (PPS) in cardiac surgery patients can be halved by treatment with colchicine, an international team has shown.…
NEW YORK (Reuters Health) – Aortic root dilation is uncommon in highly trained competitive athletes and is not likely to be caused by exercise training. Consequently, aortic root…
NEW YORK (Reuters Health) – The 10-year outcomes data from the MASS II trial comparing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and medical treatment for…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy for a year improves cardiac size and performance in patients with mildly symptomatic heart failure, resulting in improved outcomes, according…
NEW YORK (Reuters Health) – Rapid fluid replenishment “remarkably” improves the detection rate of patent foramen ovale (PFO) by transesophageal echocardiography, a multicenter team reports in the American…
NEW YORK (Reuters Health) – As long as eligibility criteria are strictly followed, it is safe to let “real world” patients undergoing percutaneous coronary intervention go home on…
NEW YORK (Reuters Health) – The use of angiotensin blocking therapy before cardiac surgery is not associated with postoperative atrial fibrillation (AF), researchers report in the August American…
NEW YORK (Reuters Health) – In high-risk patients having percutaneous coronary intervention for ST-segment elevation acute myocardial infarction (STEMI), bivalirudin was more effective than unfractionated heparin plus a…